Single-dose administration of factor VIIa
US7419949B2 · kind B2 · utility
20Cited by
4References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 16, 2002 |
| Grant date | Sep 2, 2008 |
| Priority date | — |
| Expiry date | Jul 23, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21021
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of Factor VIIa or a Factor VIIa equivalent. Preferably, the single dose comprises between about 150 and about 500 μg/kg Factor VIIa or Factor VIIa equivalent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.